Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David H Munn

Showing results (41-50 of 150) with videos related to

Pageof 15
Sort By:
Annals of the New York Academy of Sciences|June 26, 2002
Immunological concerns with bioengineering approachesDavid M Harlan, Christopher L Karp, Polly Matzinger, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cellsSandeep Artham, Arti Verma, Abdulrahman Alwhaibi, et al.
Blood|May 26, 2009
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cellsDavid J Chung, Marco Rossi, Emanuela Romano, et al.
Blood|October 16, 2009
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Annals of the New York Academy of Sciences|June 26, 2002
Immune response to engineered tissues and cells: breakout session summaryDavid M Harlan, Dennis W Metzger, Christopher L Karp, et al.
Molecular Cancer Therapeutics|June 10, 2010
Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenaseRichard Metz, James B Duhadaway, Sonja Rust, et al.
Blood|August 4, 2012
Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapyZhi-Chun Ding, Lei Huang, Bruce R Blazar, et al.
Journal of Reproductive Immunology|October 19, 2002
Indoleamine 2,3-dioxygenase, immunosuppression and pregnancyAndrew L Mellor, Phillip Chandler, Geon Kook Lee, et al.
Immunity|May 17, 2005
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Babak Baban, et al.
Journal of Cellular Physiology|July 31, 2010
αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-κB activationAlexander S Antonov, Galina N Antonova, David H Munn, et al.
Pageof 15

Showing results (41-50 of 150) with videos related to

Sort By:
Pageof 15
Annals of the New York Academy of Sciences|June 26, 2002
Immunological concerns with bioengineering approachesDavid M Harlan, Christopher L Karp, Polly Matzinger, et al.
American Journal of Physiology. Lung Cellular and Molecular Physiology|February 20, 2020
Delayed Akt suppression in the lipopolysaccharide-induced acute lung injury promotes resolution that is associated with enhanced effector regulatory T cellsSandeep Artham, Arti Verma, Abdulrahman Alwhaibi, et al.
Blood|May 26, 2009
Indoleamine 2,3-dioxygenase-expressing mature human monocyte-derived dendritic cells expand potent autologous regulatory T cellsDavid J Chung, Marco Rossi, Emanuela Romano, et al.
Blood|October 16, 2009
Inducing the tryptophan catabolic pathway, indoleamine 2,3-dioxygenase (IDO), for suppression of graft-versus-host disease (GVHD) lethalityLisa K Jasperson, Christoph Bucher, Angela Panoskaltsis-Mortari, et al.
Annals of the New York Academy of Sciences|June 26, 2002
Immune response to engineered tissues and cells: breakout session summaryDavid M Harlan, Dennis W Metzger, Christopher L Karp, et al.
Molecular Cancer Therapeutics|June 10, 2010
Zinc protoporphyrin IX stimulates tumor immunity by disrupting the immunosuppressive enzyme indoleamine 2,3-dioxygenaseRichard Metz, James B Duhadaway, Sonja Rust, et al.
Blood|August 4, 2012
Polyfunctional CD4⁺ T cells are essential for eradicating advanced B-cell lymphoma after chemotherapyZhi-Chun Ding, Lei Huang, Bruce R Blazar, et al.
Journal of Reproductive Immunology|October 19, 2002
Indoleamine 2,3-dioxygenase, immunosuppression and pregnancyAndrew L Mellor, Phillip Chandler, Geon Kook Lee, et al.
Immunity|May 17, 2005
GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenaseDavid H Munn, Madhav D Sharma, Babak Baban, et al.
Journal of Cellular Physiology|July 31, 2010
αVβ3 integrin regulates macrophage inflammatory responses via PI3 kinase/Akt-dependent NF-κB activationAlexander S Antonov, Galina N Antonova, David H Munn, et al.
Pageof 15